Skip to main content

GenTel Obtains Rights From Van Andel Research Institute to Sell Protein Array Tool

NEW YORK (GenomeWeb News) – The Van Andel Research Institute granted GenTel Biosciences exclusive rights to use its technology to commercialize a microarray platform that measures variations in protein glycosylation.
 
GenTel plans to use the technology with its PANDEIAT system to label serum proteins and probe cancer biomarker-specific antibody arrays to measure both the protein abundance and the degree of protein glycosylation, the company said.
 
Financial details were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.